Table 2.
Clinical and demographic information for the 19 pediatric patients with COVID-19 disease and auto-Abs neutralizing type I IFNs
| Patient | Age | Sex | Country of origin | Country of residence | Classification |
|---|---|---|---|---|---|
| P1 | 10 | M | Turkey | Turkey | Critical |
| P2 | 14 | F | France | France | Severe |
| P3 | 12 | F | Turkey | Turkey | Critical |
| P4 | 17 | F | Turkey | Turkey | Critical |
| P5 | 17 | M | Turkey | Turkey | Moderate |
| P6 | 3 | M | Turkey | Turkey | MIS-C + critical |
| P7 | 15 | M | Turkey | Turkey | Critical |
| P8 | 18 | M | France | France | Critical |
| P9 | 18 | M | Turkey | Turkey | Critical |
| P10 | 0.25 | F | Turkey | Turkey | Critical |
| P11 | 0.5 | F | France | France | Critical |
| P12 | 14 | M | Turkey | Turkey | Severe |
| P13 | 7.3 | M | Turkey | Turkey | Severe |
| P14 | 11 | F | Pakistan | Italy | Severe |
| P15 | 4 | F | Turkey | Turkey | Critical |
| P16 | 13 | M | Turkey | Turkey | Critical |
| P17 | 15 | F | Turkey | Turkey | Critical |
| P18 | 16 | F | Turkey | Turkey | Critical |
| P19 | 2 | F | Spain | Spain | Critical |
F: female; M: male.